{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:14:06Z","timestamp":1780460046488,"version":"3.54.1"},"reference-count":40,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"crossref","award":["N008681-385013"],"award-info":[{"award-number":["N008681-385013"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Pulmonol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1002\/ppul.23763","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T11:28:38Z","timestamp":1500895718000},"page":"1157-1162","source":"Crossref","is-referenced-by-count":30,"title":["Prevalence of hearing and vestibular loss in cystic fibrosis patients exposed to aminoglycosides"],"prefix":"10.1002","volume":"52","author":[{"given":"Jaynee A.","family":"Handelsman","sequence":"first","affiliation":[{"name":"University of Michigan Medical School; Ann Arbor Michigan"},{"name":"University of Michigan Health System; Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4124-316X","authenticated-orcid":false,"given":"Samya Z.","family":"Nasr","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology; Department of Pediatrics and Communicable Diseases; University of Michigan Health System; Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Pitts","sequence":"additional","affiliation":[{"name":"University of Michigan Health System; Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"King","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School; Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"key":"10.1002\/ppul.23763-BIB0001|ppul23763-cit-0001","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.2010.563","article-title":"Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with pseudomonas aeruginosa: a randomized controlled trial","volume":"303","author":"Saiman","year":"2010","journal-title":"JAMA"},{"key":"10.1002\/ppul.23763-BIB0002|ppul23763-cit-0002","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijporl.2010.01.021","article-title":"Hearing loss in cystic fibrosis","volume":"74","author":"Martins","year":"2010","journal-title":"International Journal of Pediatric Otorhinolaryngology"},{"key":"10.1002\/ppul.23763-BIB0003|ppul23763-cit-0003","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2165\/00003495-200060050-00006","article-title":"The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way","volume":"60","author":"Banerjee","year":"2000","journal-title":"Drugs"},{"key":"10.1002\/ppul.23763-BIB0004|ppul23763-cit-0004","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S1569-1993(11)60011-8","article-title":"Chronic pseudomonas aeruginosa infection definition: EuroCareCF working group report","volume":"10","author":"Pressler","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1002\/ppul.23763-BIB0005|ppul23763-cit-0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.mcp.0000245711.43891.16","article-title":"Update on treatment of pulmonary exacerbations in cystic fibrosis","volume":"12","author":"Smyth","year":"2006","journal-title":"Curr Opin Pulm Med"},{"key":"10.1002\/ppul.23763-BIB0006|ppul23763-cit-0006","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000027737","article-title":"Reversible tobramycin-induced bilateral high-frequency vestibular toxicity","volume":"62","author":"Walsh","year":"2000","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1002\/ppul.23763-BIB0007|ppul23763-cit-0007","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0042-1748142","article-title":"Acquired bilateral peripheral vestibular system impairment: rehabilitative options and potential outcomes","volume":"11","author":"Calder","year":"2000","journal-title":"J Am Acad Audiol"},{"key":"10.1002\/ppul.23763-BIB0008|ppul23763-cit-0008","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/14992027.2010.524253","article-title":"Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: a study using extended high-frequency audiometry and distortion product otoacoustic emissions","volume":"50","author":"Al-Malky","year":"2011","journal-title":"Int J Audiol"},{"key":"10.1002\/ppul.23763-BIB0009|ppul23763-cit-0009","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jcf.2014.01.014","article-title":"Safety of inhaled (Tobi\u00ae) and intravenous tobramycin in young children with cystic fibrosis","volume":"13","author":"Hennig","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1002\/ppul.23763-BIB0010|ppul23763-cit-0010","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/00016480050218627","article-title":"Vestibular and cochlear toxicity of aminoglycosides-a review","volume":"120","author":"Nakashima","year":"2000","journal-title":"Acta Oto-Laryngologica"},{"key":"10.1002\/ppul.23763-BIB0011|ppul23763-cit-0011","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/thx.2009.131532","article-title":"Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis","volume":"65","author":"Prayle","year":"2010","journal-title":"Thorax"},{"key":"10.1002\/ppul.23763-BIB0012|ppul23763-cit-0012","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ppul.1047","article-title":"Renal failure and vestibular toxicity in an adolescent with cystic fibrosis receiving gentamicin and standard-dose ibuprofen","volume":"31","author":"Scott","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/ppul.23763-BIB0013|ppul23763-cit-0013","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1044\/hhd9.1.10","article-title":"Objective measures of ototoxicity","volume":"9","author":"Leigh-Paffenroth","year":"2005","journal-title":"Perspectives on Hearing and Hearing Disorders: Research and Diagnostics"},{"key":"10.1002\/ppul.23763-BIB0014|ppul23763-cit-0014","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1044\/hhd9.1.17","article-title":"Audiological monitoring of patients receiving ototoxic drugs","volume":"9","author":"Konrad-Martin","year":"2005","journal-title":"Perspectives on Hearing and Hearing Disorders: Research and Diagnostics"},{"key":"10.1002\/ppul.23763-BIB0015|ppul23763-cit-0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jac\/5.3.257","article-title":"Tobramycin ototoxicity. Repeated courses of high dosage treatment in children with cystic fibrosis","volume":"5","author":"Thomsen","year":"1979","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/ppul.23763-BIB0016|ppul23763-cit-0016","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/00016480801968534","article-title":"Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients","volume":"129","author":"Scheenstra","year":"2009","journal-title":"Acta Otolaryngol"},{"key":"10.1002\/ppul.23763-BIB0017|ppul23763-cit-0017","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00020840-200010000-00001","article-title":"Integrated clinical and laboratory vestibular evaluation","volume":"8","author":"Paydarfar","year":"2000","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1002\/ppul.23763-BIB0018|ppul23763-cit-0018","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.otc.2011.01.004","article-title":"Dizziness and vertigo in the adolescent","volume":"44","author":"Taylor","year":"2011","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1002\/ppul.23763-BIB0019|ppul23763-cit-0019","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.otc.2011.01.002","article-title":"Assessment techniques for vestibular evaluation in pediatric patients","volume":"44","author":"Valente","year":"2011","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1002\/ppul.23763-BIB0020|ppul23763-cit-0020","first-page":"95","article-title":"What is useful in vestibular testing","volume":"11","author":"Wiener-Vacher","year":"2002","journal-title":"Oto-Rhino-Laryngologica"},{"key":"10.1002\/ppul.23763-BIB0021|ppul23763-cit-0021","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/14992020802334358","article-title":"Vestibular disorders in children","volume":"47","author":"Wiener-Vacher","year":"2008","journal-title":"Int J Audiol"},{"key":"10.1002\/ppul.23763-BIB0022|ppul23763-cit-0022","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/AAC.45.9.2502-2509.2001","article-title":"Stableforth. Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving and repeated high doses of aminoglycoside therapy","volume":"45","author":"Mulheran","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/ppul.23763-BIB0023|ppul23763-cit-0023","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.200109-012CC","article-title":"Aminoglycoside prescribing and surveillance in cystic fibrosis","volume":"167","author":"Tan","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.23763-BIB0024|ppul23763-cit-0024","first-page":"272","volume-title":"Pharmacology and ototoxicity for Audiologists","author":"Handelsman","year":"2006"},{"key":"10.1002\/ppul.23763-BIB0025|ppul23763-cit-0025","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s11136-011-0096-0","article-title":"Growing up with cystic fibrosis: achievement, life satisfaction, and mental health","volume":"21","author":"Besier","year":"2012","journal-title":"Qual Life Res"},{"key":"10.1002\/ppul.23763-BIB0026|ppul23763-cit-0026","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2337\/dc09-1215","article-title":"Diabetes as a determinant of mortality in cystic fibrosis","volume":"33","author":"Chamnan","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1002\/ppul.23763-BIB0027|ppul23763-cit-0027","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201009-1478CI","article-title":"Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life","volume":"183","author":"Cohen-Cymberknoh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.23763-BIB0028|ppul23763-cit-0028","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1164\/rccm.201001-0092OC","article-title":"Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis","volume":"182","author":"Nick","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.23763-BIB0029|ppul23763-cit-0029","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1183\/09031936.00079010","article-title":"Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function","volume":"37","author":"Simmonds","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1002\/ppul.23763-BIB0030|ppul23763-cit-0030","unstructured":"https:\/\/www.cff.org\/What-is-CF\/About-Cystic-Fibrosis\/"},{"key":"10.1002\/ppul.23763-BIB0031|ppul23763-cit-0031","doi-asserted-by":"crossref","first-page":"701","DOI":"10.5694\/mja11.10850","article-title":"Gentamicin ototoxicity: a 23-year selected case series of 103 patients","volume":"196","author":"Ahmed","year":"2012","journal-title":"Med J Aust"},{"key":"10.1002\/ppul.23763-BIB0032|ppul23763-cit-0032","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00129492-200109000-00018","article-title":"Recovery from vestibular ototoxicity","volume":"22","author":"Black","year":"2001","journal-title":"Otol Neurotol"},{"key":"10.1002\/ppul.23763-BIB0033|ppul23763-cit-0033","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00129492-200407000-00025","article-title":"Permanent gentamicin vestibulotoxicity","volume":"25","author":"Black","year":"2004","journal-title":"Otol Neurotol"},{"key":"10.1002\/ppul.23763-BIB0034|ppul23763-cit-0034","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/00016480600606673","article-title":"Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex","volume":"126","author":"Ishiyama","year":"2006","journal-title":"Acta Otolaryngol"},{"key":"10.1002\/ppul.23763-BIB0035|ppul23763-cit-0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1044\/hhd9.1.26","article-title":"Vestibular ototoxicity","volume":"9","author":"Handelsman","year":"2005","journal-title":"Perspectives on Hearing and Hearing Disorders: Research and Diagnostics"},{"key":"10.1002\/ppul.23763-BIB0036|ppul23763-cit-0036","first-page":"361","article-title":"Bilateral vestibulopathy revisited","volume":"1","author":"Brandt","year":"1996","journal-title":"Eur J Med Res"},{"key":"10.1002\/ppul.23763-BIB0037|ppul23763-cit-0037","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/thx.2009.131532","article-title":"Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis","volume":"65","author":"Prayle","year":"2010","journal-title":"Thorax"},{"key":"10.1002\/ppul.23763-BIB0038|ppul23763-cit-0038","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/MCP.0b013e32833eebfd","article-title":"Aminoglycoside use in cystic fibrosis: therapeutic strategies and toxicity","volume":"16","author":"Prayle","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"10.1002\/ppul.23763-BIB0039|ppul23763-cit-0039","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.otc.2011.01.001","article-title":"Development of the vestibular system and balance function: differential diagnosis in the pediatric population","volume":"44","author":"O'Reilly","year":"2011","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1002\/ppul.23763-BIB0040|ppul23763-cit-0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jcf.2014.07.009","article-title":"High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis","volume":"14","author":"Al-Malky","year":"2011","journal-title":"J Cyst Fibros"}],"container-title":["Pediatric Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fppul.23763","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/ppul.23763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T11:36:20Z","timestamp":1659267380000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ppul.23763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"URL":"https:\/\/doi.org\/10.1002\/ppul.23763","archive":["Portico"],"relation":{},"ISSN":["8755-6863"],"issn-type":[{"value":"8755-6863","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7,24]]}}}